Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Derby

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|March 30, 1991
Validation of information recorded on general practitioner based computerised data resource in the United KingdomH Jick, S S Jick, L E Derby
Journal of Clinical Psychopharmacology|August 1, 1992
Antidepressant drugs and suicideL E Derby, H Jick, A D Dean
BMJ (Clinical Research Ed.)|May 8, 2000
Risk of suicide among users of calcium channel blockers: population based, nested case-control studyC Gasse, L E Derby, C Vasilakis, et al.
Pharmacotherapy|June 10, 1998
The risk of seizures associated with tramadolH Jick, L E Derby, C Vasilakis, et al.
Pharmacotherapy|May 1, 1996
The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertensionH Jick, L E Derby, V Gurewich, et al.
Pharmacotherapy|July 1, 1993
Liver disorders in patients receiving chlorpromazine or isoniazidL E Derby, S P Gutthann, H Jick, et al.
The Medical Journal of Australia|April 18, 1994
Flucloxacillin and cholestatic hepatitisH Jick, L E Derby, A D Dean, et al.
Pharmacotherapy|January 1, 1990
Hospitalizations because of hypoglycemia in users of animal and human insulins. 2. Experience in the United StatesS S Jick, L E Derby, K M Gross, et al.
The Medical Journal of Australia|May 3, 1993
Cholestatic hepatitis associated with flucloxacillinL E Derby, H Jick, D A Henry, et al.
Archives of Internal Medicine|February 11, 2000
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancerC R Meier, L E Derby, S S Jick, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|March 30, 1991
Validation of information recorded on general practitioner based computerised data resource in the United KingdomH Jick, S S Jick, L E Derby
Journal of Clinical Psychopharmacology|August 1, 1992
Antidepressant drugs and suicideL E Derby, H Jick, A D Dean
BMJ (Clinical Research Ed.)|May 8, 2000
Risk of suicide among users of calcium channel blockers: population based, nested case-control studyC Gasse, L E Derby, C Vasilakis, et al.
Pharmacotherapy|June 10, 1998
The risk of seizures associated with tramadolH Jick, L E Derby, C Vasilakis, et al.
Pharmacotherapy|May 1, 1996
The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertensionH Jick, L E Derby, V Gurewich, et al.
Pharmacotherapy|July 1, 1993
Liver disorders in patients receiving chlorpromazine or isoniazidL E Derby, S P Gutthann, H Jick, et al.
The Medical Journal of Australia|April 18, 1994
Flucloxacillin and cholestatic hepatitisH Jick, L E Derby, A D Dean, et al.
Pharmacotherapy|January 1, 1990
Hospitalizations because of hypoglycemia in users of animal and human insulins. 2. Experience in the United StatesS S Jick, L E Derby, K M Gross, et al.
The Medical Journal of Australia|May 3, 1993
Cholestatic hepatitis associated with flucloxacillinL E Derby, H Jick, D A Henry, et al.
Archives of Internal Medicine|February 11, 2000
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancerC R Meier, L E Derby, S S Jick, et al.
Pageof 4